免疫检查点-话题@MedSci

#免疫检查点#

164篇内容 | 6136人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1340512, encodeId=c077134051218, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=针对新型免疫检查点CEACAM1的单克隆抗体CM-24与Nivolumab联用的I/II期临床将开始, objectType=article, longId=164216, objectId=25ad16421626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ad16421626, replyNumber=0, likeNumber=84, createdTime=2019-04-15, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ad16421626, moduleTitle=针对新型免疫检查点CEACAM1的单克隆抗体CM-24与Nivolumab联用的I/II期临床将开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ad16421626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340511, encodeId=ac0913405115c, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=NJEM：免疫检查点抑制剂联合阿西替尼，治疗晚期肾癌显疗效, objectType=article, longId=163374, objectId=193a1633e443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=193a1633e443, replyNumber=0, likeNumber=117, createdTime=2019-04-02, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=193a1633e443, moduleTitle=NJEM：免疫检查点抑制剂联合阿西替尼，治疗晚期肾癌显疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=193a1633e443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340510, encodeId=a03f13405101e, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=OSE Immunotherapeutics的免疫检查点抑制剂： SIRPα单抗BI 765063获批在晚期实体瘤患者中进行1期临床研究, objectType=article, longId=161788, objectId=2b6a161e88d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b6a161e88d5, replyNumber=0, likeNumber=80, createdTime=2019-03-08, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b6a161e88d5, moduleTitle=OSE Immunotherapeutics的免疫检查点抑制剂： SIRPα单抗BI 765063获批在晚期实体瘤患者中进行1期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b6a161e88d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340509, encodeId=977f134050980, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Cell：一个新的“免疫检查点”，有望与癌症疫苗联合抗癌, objectType=article, longId=161194, objectId=07e3161194e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e3161194e9, replyNumber=0, likeNumber=95, createdTime=2019-02-28, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e3161194e9, moduleTitle=Cell：一个新的“免疫检查点”，有望与癌症疫苗联合抗癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07e3161194e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340508, encodeId=d7181340508b0, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=JAMA Oncol：HIV感染的晚期肿瘤患者可以使用免疫检查点抑制剂吗？, objectType=article, longId=161011, objectId=eff416101134, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eff416101134, replyNumber=0, likeNumber=94, createdTime=2019-02-26, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eff416101134, moduleTitle=JAMA Oncol：HIV感染的晚期肿瘤患者可以使用免疫检查点抑制剂吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eff416101134)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340507, encodeId=ed93134050e59, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Nature：抗癌效果或赶上PD-1抗体！科学家从人粪便中分离出11株菌株，不但抗癌效果惊人，且可大幅增强免疫检查点抑制剂效果, objectType=article, longId=160331, objectId=075e160331a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=075e160331a8, replyNumber=0, likeNumber=108, createdTime=2019-02-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=075e160331a8, moduleTitle=Nature：抗癌效果或赶上PD-1抗体！科学家从人粪便中分离出11株菌株，不但抗癌效果惊人，且可大幅增强免疫检查点抑制剂效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=075e160331a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340506, encodeId=cc841340506e4, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=免疫检查点抑制剂耐药机制研究进展, objectType=article, longId=159539, objectId=587615953936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=587615953936, replyNumber=0, likeNumber=108, createdTime=2019-02-07, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=587615953936, moduleTitle=免疫检查点抑制剂耐药机制研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=587615953936)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340505, encodeId=208e134050583, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Blood：单细胞测序揭示淋巴瘤再与T细胞免疫检查点的共表达基因, objectType=article, longId=158610, objectId=724f1586107d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=724f1586107d, replyNumber=0, likeNumber=93, createdTime=2019-01-23, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=724f1586107d, moduleTitle=Blood：单细胞测序揭示淋巴瘤再与T细胞免疫检查点的共表达基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=724f1586107d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340504, encodeId=0d7c1340504e0, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=JAMA Oncol：免疫检查点抑制剂相关致命性并发症你造吗？, objectType=article, longId=158207, objectId=aa7615820e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7615820e5d, replyNumber=0, likeNumber=87, createdTime=2019-01-18, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7615820e5d, moduleTitle=JAMA Oncol：免疫检查点抑制剂相关致命性并发症你造吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa7615820e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340503, encodeId=024a13405039e, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Lancet Oncol：警示！免疫检查点抑制剂会导致严重心血管毒性, objectType=article, longId=157669, objectId=97b915e6691e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b915e6691e, replyNumber=0, likeNumber=96, createdTime=2019-01-11, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b915e6691e, moduleTitle=Lancet Oncol：警示！免疫检查点抑制剂会导致严重心血管毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b915e6691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340502, encodeId=67f9134050293, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=免疫检查点抑制剂的免疫相关不良反应及管理, objectType=article, longId=157299, objectId=7c4315e299d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c4315e299d7, replyNumber=0, likeNumber=98, createdTime=2019-01-06, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c4315e299d7, moduleTitle=免疫检查点抑制剂的免疫相关不良反应及管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c4315e299d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340501, encodeId=85161340501e6, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Nature:破解免疫治疗耐药性！哈佛科学家找到了肿瘤对免疫检查点抑制剂耐药的关键基因，免疫治疗疗效有望全面提升, objectType=article, longId=157114, objectId=7b5d15e114ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b5d15e114ab, replyNumber=0, likeNumber=89, createdTime=2019-01-02, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b5d15e114ab, moduleTitle=Nature:破解免疫治疗耐药性！哈佛科学家找到了肿瘤对免疫检查点抑制剂耐药的关键基因，免疫治疗疗效有望全面提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b5d15e114ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340500, encodeId=f759134050040, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=CLIN CANCER RES：吉西他滨联合免疫检查点抑制剂可以克服间皮瘤耐药, objectType=article, longId=156437, objectId=08cb15643ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08cb15643ef0, replyNumber=0, likeNumber=86, createdTime=2018-12-24, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08cb15643ef0, moduleTitle=CLIN CANCER RES：吉西他滨联合免疫检查点抑制剂可以克服间皮瘤耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08cb15643ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340499, encodeId=a9d113404991c, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异, objectType=article, longId=156411, objectId=26a0156411e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26a0156411e1, replyNumber=0, likeNumber=145, createdTime=2018-12-24, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26a0156411e1, moduleTitle=Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26a0156411e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340498, encodeId=8e17134049886, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=J Thorac Oncol：免疫检查点抑制剂治疗NSCLC 肺炎偶发or频频造访？, objectType=article, longId=155113, objectId=711c1551136c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711c1551136c, replyNumber=0, likeNumber=85, createdTime=2018-12-06, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711c1551136c, moduleTitle=J Thorac Oncol：免疫检查点抑制剂治疗NSCLC 肺炎偶发or频频造访？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711c1551136c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340497, encodeId=f930134049e0a, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=BMJ：免疫检查点抑制剂安全性比较研究, objectType=article, longId=153337, objectId=d9d315333ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d315333ecb, replyNumber=0, likeNumber=85, createdTime=2018-11-14, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d315333ecb, moduleTitle=BMJ：免疫检查点抑制剂安全性比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9d315333ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340496, encodeId=d0781340496b9, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来, objectType=article, longId=150663, objectId=bd0d15066364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd0d15066364, replyNumber=0, likeNumber=99, createdTime=2018-10-11, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd0d15066364, moduleTitle=Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd0d15066364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340495, encodeId=34f11340495ea, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Arthritis Rheumatol：与免疫检查点抑制剂相关的风湿综合征, objectType=article, longId=150453, objectId=15f9150453a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15f9150453a9, replyNumber=0, likeNumber=88, createdTime=2018-10-08, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15f9150453a9, moduleTitle=Arthritis Rheumatol：与免疫检查点抑制剂相关的风湿综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15f9150453a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340494, encodeId=cb06134049468, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Nat Med：TIDE评分，创新性的免疫检查点抑制治疗预后评估方案, objectType=article, longId=148041, objectId=6f5e1480413f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5e1480413f, replyNumber=0, likeNumber=114, createdTime=2018-09-03, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5e1480413f, moduleTitle=Nat Med：TIDE评分，创新性的免疫检查点抑制治疗预后评估方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f5e1480413f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340493, encodeId=00d3134049322, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Neurology：免疫检查点抑制剂治疗相关神经肌病的特征及预后, objectType=article, longId=146554, objectId=84b21465547a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b21465547a, replyNumber=0, likeNumber=85, createdTime=2018-08-15, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b21465547a, moduleTitle=Neurology：免疫检查点抑制剂治疗相关神经肌病的特征及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b21465547a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫检查点

2020-05-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

针对新型免疫检查点CEACAM1的单克隆抗体CM-24与Nivolumab联用的I/II期临床将开始

2019-04-15

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

NJEM：免疫检查点抑制剂联合阿西替尼，治疗晚期肾癌显疗效

2019-04-02

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

OSE Immunotherapeutics的免疫检查点抑制剂： SIRPα单抗BI 765063获批在晚期实体瘤患者中进行1期临床研究

2019-03-08

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Cell：一个新的“免疫检查点”，有望与癌症疫苗联合抗癌

2019-02-28

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

JAMA Oncol：HIV感染的晚期肿瘤患者可以使用免疫检查点抑制剂吗？

2019-02-26

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Nature：抗癌效果或赶上PD-1抗体！科学家从人粪便中分离出11株菌株，不但抗癌效果惊人，且可大幅增强免疫检查点抑制剂效果

2019-02-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

免疫检查点抑制剂耐药机制研究进展

2019-02-07

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Blood：单细胞测序揭示淋巴瘤再与T细胞免疫检查点的共表达基因

2019-01-23

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

JAMA Oncol：免疫检查点抑制剂相关致命性并发症你造吗？

2019-01-18

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Lancet Oncol：警示！免疫检查点抑制剂会导致严重心血管毒性

2019-01-11

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

免疫检查点抑制剂的免疫相关不良反应及管理

2019-01-06

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Nature:破解免疫治疗耐药性！哈佛科学家找到了肿瘤对免疫检查点抑制剂耐药的关键基因，免疫治疗疗效有望全面提升

2019-01-02

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

CLIN CANCER RES：吉西他滨联合免疫检查点抑制剂可以克服间皮瘤耐药

2018-12-24

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异

2018-12-24

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

J Thorac Oncol：免疫检查点抑制剂治疗NSCLC 肺炎偶发or频频造访？

2018-12-06

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

BMJ：免疫检查点抑制剂安全性比较研究

2018-11-14

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Cell：B7-H1/PD-1通路不仅仅是另一个“免疫检查点” 未来肿瘤免疫疗法展望，免疫正常化疗法时代已来

2018-10-11

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Arthritis Rheumatol：与免疫检查点抑制剂相关的风湿综合征

2018-10-08

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Nat Med：TIDE评分，创新性的免疫检查点抑制治疗预后评估方案

2018-09-03

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Neurology：免疫检查点抑制剂治疗相关神经肌病的特征及预后

2018-08-15

科室
- - 订阅+
  - 更多科室
工具
服务